173 related articles for article (PubMed ID: 20723438)
1. [Value of diffusion weighted imaging (DWI) in evaluating early response to neoadjuvant chemotherapy in locally advanced breast cancer].
Wang XH; Peng WJ; Tan HN; Xin C; Gu YJ; Tang F; Mao J
Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):377-81. PubMed ID: 20723438
[TBL] [Abstract][Full Text] [Related]
2. [Value of dynamic contrast-enhanced MRI in assessment of early response to neoadjuvant chemotherapy in breast cancer].
Wang XH; Peng WJ; Xin C; Tan HN; Gu YJ; Tang F; Mao J
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):539-43. PubMed ID: 21029700
[TBL] [Abstract][Full Text] [Related]
3. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
4. MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy?
McGuire KP; Toro-Burguete J; Dang H; Young J; Soran A; Zuley M; Bhargava R; Bonaventura M; Johnson R; Ahrendt G
Ann Surg Oncol; 2011 Oct; 18(11):3149-54. PubMed ID: 21947592
[TBL] [Abstract][Full Text] [Related]
5. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging in predicting pathological response of triple negative breast cancer following neoadjuvant chemotherapy.
Chen JH; Mehta RS; Carpenter PM; Nalcioglu O; Su MY
J Clin Oncol; 2007 Dec; 25(35):5667-9. PubMed ID: 18065744
[No Abstract] [Full Text] [Related]
7. Residual specimen cellularity after neoadjuvant chemotherapy for breast cancer.
Peintinger F; Kuerer HM; McGuire SE; Bassett R; Pusztai L; Symmans WF
Br J Surg; 2008 Apr; 95(4):433-7. PubMed ID: 18161887
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
Nilsen L; Fangberget A; Geier O; Olsen DR; Seierstad T
Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
[TBL] [Abstract][Full Text] [Related]
9. Preoperative taxane-based chemotherapy in a standardized protocol for locally advanced breast cancer.
Chan A; Willsher PC; Hastrich DJ; Anderson J; Barham T; Latham B; Redfern A; VAN DER Schaaf A; Thomson J; Joseph D; Ingram D
Asia Pac J Clin Oncol; 2012 Mar; 8(1):62-70. PubMed ID: 22369445
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging and ultrasonography in predicting infiltrating residual disease after preoperative chemotherapy in stage II-III breast cancer.
Guarneri V; Pecchi A; Piacentini F; Barbieri E; Dieci MV; Ficarra G; Tazzioli G; Frassoldati A; Battista R; Canossi B; Mauri C; D'Amico R; Conte P; Torricelli P
Ann Surg Oncol; 2011 Aug; 18(8):2150-7. PubMed ID: 21301969
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients.
Croshaw R; Shapiro-Wright H; Svensson E; Erb K; Julian T
Ann Surg Oncol; 2011 Oct; 18(11):3160-3. PubMed ID: 21947594
[TBL] [Abstract][Full Text] [Related]
12. Role of the Intravoxel Incoherent Motion Diffusion Weighted Imaging in the Pre-treatment Prediction and Early Response Monitoring to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
Che S; Zhao X; Ou Y; Li J; Wang M; Wu B; Zhou C
Medicine (Baltimore); 2016 Jan; 95(4):e2420. PubMed ID: 26825883
[TBL] [Abstract][Full Text] [Related]
13. Determining the morphological features of breast cancer and predicting the effects of neoadjuvant chemotherapy via diagnostic breast imaging.
Tsunoda-Shimizu H; Hayashi N; Hamaoka T; Kawasaki T; Tsugawa K; Yagata H; Kikuchi M; Suzuki K; Nakamura S
Breast Cancer; 2008; 15(2):133-40. PubMed ID: 18288570
[TBL] [Abstract][Full Text] [Related]
14. The role of PET CT to evaluate the response to neoadjuvant chemotherapy in advanced breast cancer: comparison with ultrasonography and magnetic resonance imaging.
Choi JH; Lim HI; Lee SK; Kim WW; Kim SM; Cho E; Ko EY; Han BK; Park YH; Ahn JS; Im YH; Lee JE; Yang JH; Nam SJ
J Surg Oncol; 2010 Oct; 102(5):392-7. PubMed ID: 19877158
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype.
Loo CE; Straver ME; Rodenhuis S; Muller SH; Wesseling J; Vrancken Peeters MJ; Gilhuijs KG
J Clin Oncol; 2011 Feb; 29(6):660-6. PubMed ID: 21220595
[TBL] [Abstract][Full Text] [Related]
16. Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy.
Akazawa K; Tamaki Y; Taguchi T; Tanji Y; Miyoshi Y; Kim SJ; Ueda S; Yanagisawa T; Sato Y; Tamura S; Noguchi S
Breast J; 2006; 12(2):130-7. PubMed ID: 16509837
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
Sharma U; Danishad KK; Seenu V; Jagannathan NR
NMR Biomed; 2009 Jan; 22(1):104-13. PubMed ID: 18384182
[TBL] [Abstract][Full Text] [Related]
18. [Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy].
Sinn HP; Schmid H; Junkermann H; Huober J; Leppien G; Kaufmann M; Bastert G; Otto HF
Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):552-8. PubMed ID: 8001751
[TBL] [Abstract][Full Text] [Related]
19. MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy.
Belli P; Costantini M; Malaspina C; Magistrelli A; LaTorre G; Bonomo L
Clin Radiol; 2006 Nov; 61(11):946-53. PubMed ID: 17018307
[TBL] [Abstract][Full Text] [Related]
20. Histopathologic correlation of residual mammographic microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer.
Adrada BE; Huo L; Lane DL; Arribas EM; Resetkova E; Yang W
Ann Surg Oncol; 2015 Apr; 22(4):1111-7. PubMed ID: 25287438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
